NIH pauses stem cell trial after Brigham calls to retract 'fabricated' foundational research

NIH's National Heart, Lung, and Blood Institute (NHLBI) said Monday it will pause the Phase II CONCERT-HF trial testing a cardiac stem cell therapy as recent calls for retraction of journal articles in related research fields have "raised concerns about the scientific foundations of the trial."